Clinical Trial Update: Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compared palonosetron to ondansetron for the prevention of chemotherapy-induced nausea and vomiting in patients with acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aloxi (palonosetron hydrochloride)
• Zofran (Ondansetron)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia, Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2011-02-03